Pielka, M., Schneider, T., Terheyden, J., & Sifa, R. (2024). [Vision Paper] PRObot: Enhancing Patient-Reported Outcome Measures for Diabetic Retinopathy using Chatbots and Generative AI. In Proceedings of the IEEE Big Data 2024 Conference. IEEE.
This vision paper proposes a novel framework called PRObot to address the limitations of traditional static PROMs in diabetic retinopathy management by leveraging LLMs for dynamic and personalized patient interaction and data analysis.
The paper outlines a conceptual framework for PRObot, comprising three main components:
The authors propose using GPT-4o for chatbot interaction and simulating synthetic patient data for initial qualitative evaluation. Future work involves data collection through surveys and clinical studies to train and validate the system using the NEI-VFQ-25 PROM as a reference.
The paper presents preliminary qualitative results from simulated patient interactions, demonstrating PRObot's ability to:
The authors argue that PRObot has the potential to revolutionize diabetic retinopathy management by:
This research highlights the potential of LLMs and AI-driven chatbots in transforming healthcare by improving patient-reported data collection and analysis, particularly for chronic diseases like diabetic retinopathy.
The proposed framework requires further validation through large-scale data collection, model training, and clinical evaluation. Future research should focus on:
To Another Language
from source content
arxiv.org
Key Insights Distilled From
by Maren Pielka... at arxiv.org 11-06-2024
https://arxiv.org/pdf/2411.02973.pdfDeeper Inquiries